Vimarsana
Biggest News Aggregation in the World

Subgroup Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Subgroup Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Subgroup Data Today - Breaking & Trending Today

Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma - Vimarsana News

Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...

A Social Network Analysis of the Guerreros Unidos Crime Syndicate - Vimarsana News

A Social Network Analysis of the Guerreros Unidos Crime Syndicate

Guerreros Unidos, a transnational crime organization (TCO) based in the Mexican state of Guerrero, has been linked to violent crimes, including the disappearance of 43 university students in 2014. The organization’s history of widespread violence, drug trafficking, corruption, and other crimes has made the Guerreros Unidos a notable concern to both the United States and Mexico. Understanding how this illicit network operates can provide valuable information on how to disrupt other transnational crime organizations. Social network analysis was used to map the relationships of members of the o...

Karyopharm to Present Selinexor Data at the 2023 International Myeloma Society Annual Meeting and European Society of Gynaecological Oncology 2023 Annual Meetings - Vimarsana News

Karyopharm to Present Selinexor Data at the 2023 International Myeloma Society Annual Meeting and European Society of Gynaecological Oncology 2023 Annual Meetings

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

Menarini Industrie Farmaceutiche Riunite: Menarini Group Shares NEXPOVIO® (selinexor) Subgroup Data from BOSTON trial at the European Hematology Association Congress, Highlighting Clinical Potential in Relapsed/Refractory Multiple Myeloma - Vimarsana News

Menarini Industrie Farmaceutiche Riunite: Menarini Group Shares NEXPOVIO® (selinexor) Subgroup Data from BOSTON trial at the European Hematology Association Congress, Highlighting Clinical Potential in Relapsed/Refractory Multiple Myeloma

Data demonstrate a significant 71% reduction in risk of disease progression or death in selinexor + bortezomib + dexamethasone (SVd) arm versus bortezomib + dexamethasone (Vd) arm in PI-naïve